---

Recent Presentations:

Human Mesenchymal Stromal Cells Exert Renoprotective and Pro-Survival Effects in Mice with Cisplatin-Induced Acute Renal Failure.
Oral Presentation at the International Society for Cellular Therapy Annual Meeting, San Diego, May 4, 2009.

---

Recent Publications:

Benabdallah, B.F., Allard, E., Yao, S., Friedman, G., Gregory, PD, Eliopoulos, N., Fradette, J., Spees, J.L., Holmes, M.C., and Beauséjour, C.M.
Targeted Gene Addition to Human Mesenchymal Stromal Cells as a Cell-Based Plasma-Soluble Protein Delivery Platform. Cytotherapy 12(3): 394-397, 2010.

Corcos, J., Loutochin, O., Campeau, L., Eliopoulos, N., Bouchentouf, M., Blok, B., and Galipeau, J.
Bone marrow mesenchymal Stromal Cell Therapy for external Urethral Sphincter Restoration in a Rat Model of stress Urinary Incontinence. Neurourology and Urodynamics, In Press. 2010 Nov.2 [Epub ahead of print].

Eliopoulos, N.*, Zhao, J., Bouchentouf, M., Forner, K., Birman, E., Yuan, S., Boivin, M.N., and Martineau D.
Human Marrow-Derived Mesenchymal Stromal Cells Decrease Cisplatin Renotoxicity In Vitro and In Vivo, and Enhance Survival of Mice Post Intraperitoneal Injection. American Journal of Physiology - Renal Physiology, In Press. 2010 Sep.15 [Epub ahead of print].